vs
Side-by-side financial comparison of PLAYSTUDIOS, Inc. (MYPS) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $55.4M, roughly 1.4× PLAYSTUDIOS, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -18.3%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $3.6M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -15.6%).
PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
MYPS vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.4M | $75.5M |
| Net Profit | $-13.7M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | -17.7% | 22.7% |
| Net Margin | -24.7% | — |
| Revenue YoY | -18.3% | 27.7% |
| Net Profit YoY | 38.9% | — |
| EPS (diluted) | $-0.12 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.4M | $75.5M | ||
| Q3 25 | $57.6M | $54.5M | ||
| Q2 25 | $59.3M | $52.4M | ||
| Q1 25 | $62.7M | $46.0M | ||
| Q4 24 | $67.8M | $59.1M | ||
| Q3 24 | $71.2M | $80.5M | ||
| Q2 24 | $72.6M | $47.1M | ||
| Q1 24 | $77.8M | $43.8M |
| Q4 25 | $-13.7M | — | ||
| Q3 25 | $-9.1M | $8.8M | ||
| Q2 25 | $-2.9M | $5.9M | ||
| Q1 25 | $-2.9M | $3.0M | ||
| Q4 24 | $-22.4M | — | ||
| Q3 24 | $-3.1M | $20.3M | ||
| Q2 24 | $-2.6M | $-4.5M | ||
| Q1 24 | $-567.0K | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | -17.7% | 22.7% | ||
| Q3 25 | -13.6% | 17.6% | ||
| Q2 25 | -5.9% | 12.7% | ||
| Q1 25 | -4.4% | 8.7% | ||
| Q4 24 | -33.1% | 22.6% | ||
| Q3 24 | -6.7% | 27.4% | ||
| Q2 24 | -5.5% | -4.6% | ||
| Q1 24 | -2.2% | -5.3% |
| Q4 25 | -24.7% | — | ||
| Q3 25 | -15.8% | 16.2% | ||
| Q2 25 | -5.0% | 11.2% | ||
| Q1 25 | -4.6% | 6.5% | ||
| Q4 24 | -33.1% | — | ||
| Q3 24 | -4.3% | 25.2% | ||
| Q2 24 | -3.6% | -9.6% | ||
| Q1 24 | -0.7% | -11.0% |
| Q4 25 | $-0.12 | $0.26 | ||
| Q3 25 | $-0.07 | $0.17 | ||
| Q2 25 | $-0.02 | $0.12 | ||
| Q1 25 | $-0.02 | $0.06 | ||
| Q4 24 | $-0.18 | $0.40 | ||
| Q3 24 | $-0.02 | $0.41 | ||
| Q2 24 | $-0.02 | $-0.09 | ||
| Q1 24 | $0.00 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $104.9M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $227.9M | $130.3M |
| Total Assets | $290.6M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $104.9M | $97.5M | ||
| Q3 25 | $106.3M | $94.4M | ||
| Q2 25 | $112.9M | $96.0M | ||
| Q1 25 | $107.1M | $93.2M | ||
| Q4 24 | $109.2M | $101.0M | ||
| Q3 24 | $105.2M | $96.7M | ||
| Q2 24 | $106.3M | $96.8M | ||
| Q1 24 | $127.0M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $227.9M | $130.3M | ||
| Q3 25 | $238.9M | $115.3M | ||
| Q2 25 | $245.3M | $104.7M | ||
| Q1 25 | $244.1M | $97.1M | ||
| Q4 24 | $244.7M | $92.1M | ||
| Q3 24 | $265.2M | $71.1M | ||
| Q2 24 | $263.6M | $48.5M | ||
| Q1 24 | $288.4M | $51.0M |
| Q4 25 | $290.6M | $216.3M | ||
| Q3 25 | $299.2M | $202.9M | ||
| Q2 25 | $316.2M | $194.9M | ||
| Q1 25 | $313.8M | $196.2M | ||
| Q4 24 | $323.0M | $213.3M | ||
| Q3 24 | $330.6M | $220.7M | ||
| Q2 24 | $333.4M | $205.0M | ||
| Q1 24 | $357.5M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.7M | $14.4M |
| Free Cash FlowOCF − Capex | $3.6M | $14.4M |
| FCF MarginFCF / Revenue | 6.5% | 19.1% |
| Capex IntensityCapex / Revenue | 0.2% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $25.4M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.7M | $14.4M | ||
| Q3 25 | $5.7M | $9.7M | ||
| Q2 25 | $13.6M | $14.1M | ||
| Q1 25 | $3.3M | $3.6M | ||
| Q4 24 | $11.6M | $15.6M | ||
| Q3 24 | $14.6M | $11.0M | ||
| Q2 24 | $14.5M | $1.0M | ||
| Q1 24 | $5.0M | $11.2M |
| Q4 25 | $3.6M | $14.4M | ||
| Q3 25 | $5.4M | $9.7M | ||
| Q2 25 | $13.2M | $14.1M | ||
| Q1 25 | $3.2M | $3.6M | ||
| Q4 24 | $11.5M | $15.6M | ||
| Q3 24 | $13.9M | $11.0M | ||
| Q2 24 | $12.8M | $1.0M | ||
| Q1 24 | $3.6M | — |
| Q4 25 | 6.5% | 19.1% | ||
| Q3 25 | 9.3% | 17.7% | ||
| Q2 25 | 22.3% | 26.8% | ||
| Q1 25 | 5.1% | 7.7% | ||
| Q4 24 | 16.9% | 26.4% | ||
| Q3 24 | 19.6% | 13.7% | ||
| Q2 24 | 17.6% | 2.1% | ||
| Q1 24 | 4.6% | — |
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.5% | 0.0% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 0.2% | 0.0% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 2.4% | 0.0% | ||
| Q1 24 | 1.9% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
